$65.53
-1.29 (-1.93%)
At Close: Jun 03, 2026
Utah Medical Products, Inc. Announces Quarterly Dividend
10:00am, Tuesday, 05'th May 2026
SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per s
Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs
01:31pm, Wednesday, 29'th Apr 2026
UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet.
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
09:00am, Thursday, 23'rd Apr 2026
SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its
Head-To-Head Comparison: Utah Medical Products (NASDAQ:UTMD) and INLIF (NASDAQ:INLF)
04:11am, Saturday, 18'th Apr 2026
Utah Medical Products (NASDAQ: UTMD - Get Free Report) and INLIF (NASDAQ: INLF - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two comp
Utah Medical Gains 32% in a Year: Should You Buy the Stock?
02:41pm, Thursday, 16'th Apr 2026
UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from rising demand for high-quality maternal and neonatal healthcare solutions.
The Zacks Analyst Blog American Express, Intuitive Surgical, Shopify and Utah Medical Products
05:21am, Thursday, 02'nd Apr 2026
American Express leads featured reports as spending growth and digital investments drive gains, while Intuitive Surgical and Shopify show mixed momentum.
Utah Medical Products (NASDAQ:UTMD) Stock Passes Above 200 Day Moving Average – Here’s What Happened
02:57am, Wednesday, 25'th Mar 2026
Utah Medical Products, Inc. (NASDAQ: UTMD - Get Free Report) passed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $60.53 and tra
Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y
01:40pm, Wednesday, 04'th Feb 2026
UTMD's Q4 earnings fall year over year due to weak OEM sales and lower international Filshie sales, but strong U.S. Filshie growth and steady margins help offset broader revenue pressure.
Utah Medical Products, Inc. Announces Quarterly Dividend
10:00am, Wednesday, 04'th Feb 2026
SALT LAKE CITY, UT / ACCESS Newswire / February 4, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31)
UTMD Reports Year 2025 and Fourth Quarter Financial Performance
09:00am, Thursday, 29'th Jan 2026
SALT LAKE CITY, UT / ACCESS Newswire / January 29, 2026 / With some unexpected circumstances in 2025, Utah Medical Products, Inc (UTMD) did not achieve its beginning of year financial projections. Nev
Utah Medical Products (NASDAQ:UTMD) Shares Cross Above Fifty Day Moving Average – Time to Sell?
04:52am, Tuesday, 06'th Jan 2026
Shares of Utah Medical Products, Inc. (NASDAQ: UTMD - Get Free Report) crossed above its 50-day moving average during trading on Monday. The stock has a 50-day moving average of $56.49 and traded as h
Comparing Utah Medical Products (NASDAQ:UTMD) and Terumo (OTCMKTS:TRUMY)
02:24am, Tuesday, 06'th Jan 2026
Terumo (OTCMKTS:TRUMY - Get Free Report) and Utah Medical Products (NASDAQ: UTMD - Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses
Utah Medical Products (NASDAQ:UTMD) Stock Crosses Below 200 Day Moving Average – Here’s What Happened
04:56am, Friday, 19'th Dec 2025
Utah Medical Products, Inc. (NASDAQ: UTMD - Get Free Report)'s share price passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $58.26 and trad
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
10:00am, Tuesday, 04'th Nov 2025
SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors.
UTMD's Q3 Earnings Dip Y/Y on Trade Disruptions, Margins Squeeze
02:31pm, Wednesday, 29'th Oct 2025
Utah Medical's Q3 earnings fell 20% year over year as order cancellations and tariffs pressured margins. Growth in U.S. Filshie devices and direct sales helped partially offset declines.
Sign In
Buy UTMD